Literature DB >> 25697540

Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old.

Eva Compérat1, Stéphane Larré, Morgan Roupret, Yann Neuzillet, Géraldine Pignot, Hervé Quintens, Nadine Houéde, Catherine Roy, Xavier Durand, Justine Varinot, Dimitri Vordos, Mathieu Rouanne, Mohammed Adnan Bakhri, Priscilla Bertrand, Stephane Calin Jeglinschi, Olivier Cussenot, Michel Soulié, Christian Pfister.   

Abstract

Urothelial bladder cancer (UBC) is rare in young patients and as a result little information as to tumor type and clinical course are available. We present clinicopathological data of a large series of patients less than 40 years with bladder carcinoma. We included in this retrospective study covering the period from 1992 to 2013 patients less than 40 years with a first diagnosis of bladder cancer. Lesions were classified according to the WHO 2004 classification by uropathologists of ten centers. Stage, grade, multifocality, smoking habits, recurrence, and survival were studied. The cohort comprised of 152 patients, 113 males and 39 females with a mean age of 33.2 years. The large majority of the patients (142) was diagnosed with an urothelial carcinoma, the ten others with various histopathological diagnoses. In the age group less than 30 years old, 40.3 % of the cases concerned a papillary urothelial neoplasia of low malignant potential (PUNLMP). In the age group over 30 years, the proportion of PUNLMP decreased to 27.2 %. Only 5.6 % of the UBC was associated with carcinoma in situ. In 14.1 %, a high grade muscle invasive UC was found; 7.0 % had lymph node and 4.9 % distant metastasis at time of presentation. Four patients presented with a history of schistosomiasis; all had an infiltrating carcinoma. After initial resection, 36 patients relapsed, 17 % as PUNLMP, 53 % as pTa low grade, and 30 % as pTa-pT2 high grade UC. During follow-up, 6 % of the patients died. PUNLMP is the most frequent entity in this patient group. It is important that the PUNLMP entity is maintained in future classification systems.

Entities:  

Mesh:

Year:  2015        PMID: 25697540     DOI: 10.1007/s00428-015-1739-2

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  13 in total

1.  Urothelial neoplasms in patients 20 years or younger: a clinicopathological analysis using the world health organization 2004 bladder consensus classification.

Authors:  Samson W Fine; Peter A Humphrey; Louis P Dehner; Mahul B Amin; Jonathan I Epstein
Journal:  J Urol       Date:  2005-11       Impact factor: 7.450

Review 2.  Morphological diagnosis of urothelial neoplasms.

Authors:  R Montironi; R Mazzucchelli; M Scarpelli; A Lopez-Beltran; L Cheng
Journal:  J Clin Pathol       Date:  2007-06-01       Impact factor: 3.411

3.  Primary epithelial tumors of the bladder in the first two decades of life.

Authors:  N Javadpour; F K Mostofi
Journal:  J Urol       Date:  1969-05       Impact factor: 7.450

Review 4.  Urothelial neoplasms of the urinary bladder occurring in young adult and pediatric patients: a comprehensive review of literature with implications for patient management.

Authors:  Gladell P Paner; Pascal Zehnder; Anmol M Amin; Aliya N Husain; Mihir M Desai
Journal:  Adv Anat Pathol       Date:  2011-01       Impact factor: 3.875

5.  Tobacco use and occupational exposure to carcinogens, but not N-acetyltransferase 2 genotypes are major risk factors for bladder cancer in the Japanese.

Authors:  K Kontani; M Kawakami; T Nakajima; T Katsuyama
Journal:  Urol Res       Date:  2001-06

6.  A prospective study on active and environmental tobacco smoking and bladder cancer risk (The Netherlands).

Authors:  Maurice P A Zeegers; R Alexandra Goldbohm; Piet A van den Brandt
Journal:  Cancer Causes Control       Date:  2002-02       Impact factor: 2.506

Review 7.  Transitional cell carcinoma of the bladder in patients under 40 years of age.

Authors:  A Erözenci; S Ataus; A Pekyalçin; A Kural; Z Talat; V Solok
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

8.  Bladder malignancies in children aged <18 years: results from the Surveillance, Epidemiology and End Results database.

Authors:  Shaheen Alanee; Aseem R Shukla
Journal:  BJU Int       Date:  2009-12-14       Impact factor: 5.588

9.  Bladder carcinoma in patients 40 years old or less.

Authors:  J M Fitzpatrick; M Reda
Journal:  J Urol       Date:  1986-01       Impact factor: 7.450

10.  Transitional cell carcinoma of the bladder in young adults: presentation, natural history and outcome.

Authors:  Ofer Yossepowitch; Guido Dalbagni
Journal:  J Urol       Date:  2002-07       Impact factor: 7.450

View more
  32 in total

1.  Muscle-invasive bladder cancer organ-preserving therapy: systematic review and meta-analysis.

Authors:  Herney Andrés García-Perdomo; Carlos Eduardo Montes-Cardona; Marcela Guacheta; Diego Fernando Castillo; Leonardo O Reis
Journal:  World J Urol       Date:  2018-06-25       Impact factor: 4.226

2.  Urothelial carcinoma in first histological diagnosis of patients over 80 years has distinctive histological features: a retrospective single-institution study of 185 patients.

Authors:  Adeline Furudoï; Justine Varinot; Véronique Phe; Morgan Roupret; Marc-Olivier Bitker; Eva Compérat
Journal:  Virchows Arch       Date:  2017-03-09       Impact factor: 4.064

3.  Urothelial neoplasms in pediatric and young adult patients: A large single-center series.

Authors:  James A Saltsman; Marcus M Malek; Victor E Reuter; William J Hammond; Enrico Danzer; Harry W Herr; Michael P LaQuaglia
Journal:  J Pediatr Surg       Date:  2017-11-14       Impact factor: 2.545

4.  Clinical behavior and survival outcome of urothelial bladder cancer in young adults.

Authors:  Shahbaz Mehmood; Khalid Ibraheem Alothman; Majed Al Rumayyan; Waleed Mohammed Altaweel; Turki Omar Alhussain
Journal:  Urol Ann       Date:  2022-04-18

5.  Determinants of Survival for Adolescents and Young Adults with Urothelial Bladder Cancer: Results from the California Cancer Registry.

Authors:  Joshua Lara; Ann Brunson; Theresa H M Keegan; Marcio Malogolowkin; Chong-Xian Pan; Stanley Yap; Ralph deVere White
Journal:  J Urol       Date:  2016-05-18       Impact factor: 7.450

6.  Urothelial bladder cancer in young adults: Diagnosis, treatment and clinical behaviour.

Authors:  Bülent Gunlusoy; Yasin Ceylan; Tansu Degirmenci; Zafer Kozacioglu; Tarık Yonguc; Halil Bozkurt; Ozgü Aydogdu; Volkan Sen
Journal:  Can Urol Assoc J       Date:  2015-10-13       Impact factor: 1.862

7.  Comparing CxBladder to Urine Cytology as Adjunct to Cystoscopy in Surveillance of Non-muscle Invasive Bladder Cancer-A Pilot Study.

Authors:  C A Chai; W S Yeoh; R Rajandram; K P Aung; T A Ong; S Kuppusamy; A Nazran; K Kumaran; A H A Razack; J Y Teoh
Journal:  Front Surg       Date:  2021-05-13

Review 8.  The Interplay between Oxidative Stress, Inflammation and Angiogenesis in Bladder Cancer Development.

Authors:  Paulina Wigner; Radosław Grębowski; Michał Bijak; Joanna Saluk-Bijak; Janusz Szemraj
Journal:  Int J Mol Sci       Date:  2021-04-25       Impact factor: 5.923

Review 9.  Differential Prognosis and Response of Denovo vs. Secondary Muscle-Invasive Bladder Cancer: An Updated Systematic Review and Meta-Analysis.

Authors:  Mario Pones; David D'Andrea; Keiichiro Mori; Mohammad Abufraj; Marco Moschini; Eva Comperat; Shahrokh F Shariat
Journal:  Cancers (Basel)       Date:  2021-05-20       Impact factor: 6.639

10.  Clinical Behavior of Bladder Urothelial Carcinoma in Young Patients: A Single Center Experience.

Authors:  Volkan Sen; Ozan Bozkurt; Omer Demir; Ahmet Adil Esen; Ugur Mungan; Guven Aslan; Aykut Kefi; Ilhan Celebi
Journal:  Scientifica (Cairo)       Date:  2016-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.